A Review on the Protective Effects of Probiotics Against Alzheimer's Disease

Overview

Journal Biology (Basel)

Publisher MDPI

Specialty Biology

Date 2024 Jan 22

PMID 38248439

Authors

Vibhuti Mishra

Dhananjay Yadav

Kavita Singh Solanki

Bhupendra Koul

Minseok Song

Affiliations

Soon will be listed here.

Abstract

This review summarizes the protective effects of probiotics against Alzheimer's disease (AD), one of the most common neurodegenerative disorders affecting older adults. This disease is characterized by the deposition of tau and amyloid β peptide (Aβ) in different parts of the brain. Symptoms observed in patients with AD include struggles with writing, speech, memory, and knowledge. The gut microbiota reportedly plays an important role in brain functioning due to its bidirectional communication with the gut via the gut-brain axis. The emotional and cognitive centers in the brain are linked to the functions of the peripheral intestinal system via this gut-brain axis. Dysbiosis has been linked to neurodegenerative disorders, indicating the significance of gut homeostasis for proper brain function. Probiotics play an important role in protecting against the symptoms of AD as they restore gut-brain homeostasis to a great extent. This review summarizes the characteristics, status of gut-brain axis, and significance of gut microbiota in AD. Review and research articles related to the role of probiotics in the treatment of AD were searched in the PubMed database. Recent studies conducted using animal models were given preference. Recent clinical trials were searched for separately. Several studies conducted on animal and human models clearly explain the benefits of probiotics in improving cognition and memory in experimental subjects. Based on these studies, novel therapeutic approaches can be designed for the treatment of patients with AD.

Citing Articles

Newer Therapeutic Approaches in Treating Alzheimer's Disease: A Comprehensive Review.

Reddi Sree R, Kalyan M, Anand N, Mani S, Gorantla V, Sakharkar M ACS Omega. 2025; 10(6):5148-5171.

PMID: 39989768 PMC: 11840625. DOI: 10.1021/acsomega.4c05527.

Probiotics and Food Bioactives: Unraveling Their Impact on Gut Microbiome, Inflammation, and Metabolic Health.

Mafe A, Edo G, Akpoghelie P, Gaaz T, Yousif E, Zainulabdeen K Probiotics Antimicrob Proteins. 2025; .

PMID: 39808399 DOI: 10.1007/s12602-025-10452-2.

Microencapsulation and nanoencapsulation of bacterial probiotics: new frontiers in Alzheimer's disease treatment.

Lavanya M, Namasivayam S, Priyanka S, Abiraamavalli T 3 Biotech. 2024; 14(12):313.

PMID: 39611008 PMC: 11599650. DOI: 10.1007/s13205-024-04158-5.

Gut dysbiosis mediates the association between antibiotic exposure and chronic disease.

Guarner F, Bustos Fernandez L, Cruchet S, Damiao A, Maruy Saito A, Riveros Lopez J Front Med (Lausanne). 2024; 11:1477882.

PMID: 39568738 PMC: 11576192. DOI: 10.3389/fmed.2024.1477882.

Lactobacillus Helveticus Improves Controlled Cortical Impact Injury-Generated Neurological Aberrations by Remodeling of Gut-Brain Axis Mediators.

Pasam T, Padhy H, Dandekar M Neurochem Res. 2024; 50(1):3.

PMID: 39541016 DOI: 10.1007/s11064-024-04251-4.

References

Zhu F, Li C, Chu F, Tian X, Zhu J . Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer's Disease. Front Aging Neurosci. 2020; 12:544235. PMC: 7572848. DOI: 10.3389/fnagi.2020.544235. View

Kim N, Yun M, Oh Y, Choi H . Mind-altering with the gut: Modulation of the gut-brain axis with probiotics. J Microbiol. 2018; 56(3):172-182. DOI: 10.1007/s12275-018-8032-4. View

Schepper J, Collins F, Rios-Arce N, Raehtz S, Schaefer L, Gardinier J . Probiotic Lactobacillus reuteri Prevents Postantibiotic Bone Loss by Reducing Intestinal Dysbiosis and Preventing Barrier Disruption. J Bone Miner Res. 2019; 34(4):681-698. PMC: 6557403. DOI: 10.1002/jbmr.3635. View

Bosi A, Banfi D, Bistoletti M, Giaroni C, Baj A . Tryptophan Metabolites Along the Microbiota-Gut-Brain Axis: An Interkingdom Communication System Influencing the Gut in Health and Disease. Int J Tryptophan Res. 2020; 13:1178646920928984. PMC: 7290275. DOI: 10.1177/1178646920928984. View

Jiang W, Gong L, Liu F, Ren Y, Mu J . Alteration of Gut Microbiome and Correlated Lipid Metabolism in Post-Stroke Depression. Front Cell Infect Microbiol. 2021; 11:663967. PMC: 8100602. DOI: 10.3389/fcimb.2021.663967. View

Nagahara A, Tuszynski M . Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat Rev Drug Discov. 2011; 10(3):209-19. DOI: 10.1038/nrd3366. View

Ambrosini Y, Borcherding D, Kanthasamy A, Kim H, Willette A, Jergens A . The Gut-Brain Axis in Neurodegenerative Diseases and Relevance of the Canine Model: A Review. Front Aging Neurosci. 2019; 11:130. PMC: 6591269. DOI: 10.3389/fnagi.2019.00130. View

Franceschi C, Garagnani P, Morsiani C, Conte M, Santoro A, Grignolio A . The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates. Front Med (Lausanne). 2018; 5:61. PMC: 5890129. DOI: 10.3389/fmed.2018.00061. View

Kanamaru T, Kamimura N, Yokota T, Iuchi K, Nishimaki K, Takami S . Oxidative stress accelerates amyloid deposition and memory impairment in a double-transgenic mouse model of Alzheimer's disease. Neurosci Lett. 2014; 587:126-31. DOI: 10.1016/j.neulet.2014.12.033. View

10.

Nimgampalle M, Kuna Y . Anti-Alzheimer Properties of Probiotic, MTCC 1325 in Alzheimer's Disease induced Albino Rats. J Clin Diagn Res. 2017; 11(8):KC01-KC05. PMC: 5620801. DOI: 10.7860/JCDR/2017/26106.10428. View

11.

Nelson A, Sweeney M, Sagare A, Zlokovic B . Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease. Biochim Biophys Acta. 2015; 1862(5):887-900. PMC: 4821735. DOI: 10.1016/j.bbadis.2015.12.016. View

12.

Chen Y, Xu J, Chen Y . Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders. Nutrients. 2021; 13(6). PMC: 8234057. DOI: 10.3390/nu13062099. View

13.

Sun J, Xu J, Yang B, Chen K, Kong Y, Fang N . Effect of Clostridium butyricum against Microglia-Mediated Neuroinflammation in Alzheimer's Disease via Regulating Gut Microbiota and Metabolites Butyrate. Mol Nutr Food Res. 2019; 64(2):e1900636. DOI: 10.1002/mnfr.201900636. View

14.

Santos S, de Oliveira H, Yamada E, Neves B, Pereira Jr A . The Gut and Parkinson's Disease-A Bidirectional Pathway. Front Neurol. 2019; 10:574. PMC: 6558190. DOI: 10.3389/fneur.2019.00574. View

15.

Singh R, Zogg H, Wei L, Bartlett A, Ghoshal U, Rajender S . Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders. J Neurogastroenterol Motil. 2020; 27(1):19-34. PMC: 7786094. DOI: 10.5056/jnm20149. View

16.

Akbari E, Asemi Z, Daneshvar Kakhaki R, Bahmani F, Kouchaki E, Tamtaji O . Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial. Front Aging Neurosci. 2016; 8:256. PMC: 5105117. DOI: 10.3389/fnagi.2016.00256. View

17.

Topiwala H, Terrera G, Stirland L, Saunderson K, Russ T, Dozier M . Lifestyle and neurodegeneration in midlife as expressed on functional magnetic resonance imaging: A systematic review. Alzheimers Dement (N Y). 2018; 4:182-194. PMC: 6021545. DOI: 10.1016/j.trci.2018.04.001. View

18.

Tamtaji O, Heidari-Soureshjani R, Mirhosseini N, Kouchaki E, Bahmani F, Aghadavod E . Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer's disease: A randomized, double-blind, controlled trial. Clin Nutr. 2019; 38(6):2569-2575. DOI: 10.1016/j.clnu.2018.11.034. View

19.

Aggeletopoulou I, Konstantakis C, Assimakopoulos S, Triantos C . The role of the gut microbiota in the treatment of inflammatory bowel diseases. Microb Pathog. 2019; 137:103774. DOI: 10.1016/j.micpath.2019.103774. View

20.

Patel C, Pande S, Acharya S . Potentiation of anti-Alzheimer activity of curcumin by probiotic Lactobacillus rhamnosus UBLR-58 against scopolamine-induced memory impairment in mice. Naunyn Schmiedebergs Arch Pharmacol. 2020; 393(10):1955-1962. DOI: 10.1007/s00210-020-01904-3. View